Andersen, H. H., Duroux, M., & Gazerani, P. (2014). MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis, 71, 159-168. doi:10.1016/j.nbd.2014.08.003
Bai, G., Ambalavanar, R., Wei, D., & Dessem, D. (2007). Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain, 3, 15. doi:10.1186/1744-8069-3-15
Bali, K. K., & Kuner, R. (2014). Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med, 20(8), 437-448. doi:10.1016/j.molmed.2014.05.006
Bao, Y. F., Wang, S. H., Xie, Y. S., Jin, K. H., Bai, Y. T., & Shan, S. G. (2018). MiR-28-5p relieves neuropathic pain by targeting Zeb1 in CCI rat models. Journal of Cellular Biochemistry, 119(10), 8555-8563. doi:10.1002/jcb.27096
Baron, R., Binder, A., & Wasner, G. (2010). Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol, 9(8), 807-819. doi:10.1016/S1474-4422(10)70143-5
Bennett, G. J., & Xie, Y. K. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33(1), 87-107. doi:10.1016/0304-3959(88)90209-6
Campbell, J. N., & Meyer, R. A. (2006). Mechanisms of neuropathic pain. Neuron, 52(1), 77-92. doi:10.1016/j.neuron.2006.09.021
Carthew, R. W., & Sontheimer, E. J. (2009). Origins and Mechanisms of miRNAs and siRNAs. Cell, 136(4), 642-655. doi:10.1016/j.cell.2009.01.035
de Moraes Vieira, E. B., Garcia, J. B., da Silva, A. A., Mualem Araujo, R. L., & Jansen, R. C. (2012). Prevalence, characteristics, and factors associated with chronic pain with and without neuropathic characteristics in Sao Luis, Brazil. J Pain Symptom Manage, 44(2), 239-251. doi:10.1016/j.jpainsymman.2011.08.014
Favereaux, A., Thoumine, O., Bouali-Benazzouz, R., Roques, V., Papon, M. A., Salam, S. A., . . . Landry, M. (2011). Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J, 30(18), 3830-3841. doi:10.1038/emboj.2011.249
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., . . . Wallace, M. (2015). Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol, 14(2), 162-173. doi:10.1016/S1474-4422(14)70251-0
Gao, Z., Wang, H., Li, H., Li, M., Wang, J., Zhang, W., . . . Tang, J. (2018). Long non-coding RNA CASC2 inhibits breast cancer cell growth and metastasis through the regulation of the miR-96-5p/SYVN1 pathway. Int J Oncol, 53(5), 2081-2090. doi:10.3892/ijo.2018.4522
Graham, T. R., Zhau, H. E., Odero-Marah, V. A., Osunkoya, A. O., Kimbro, K. S., Tighiouart, M., . . . O'Regan, R. M. (2008). Insulin-like growth factor-l-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Research, 68(7), 2479-2488. doi:10.1158/0008-5472.Can-07-2559
Guaita, S., Puig, I., Franci, C., Garrido, M., Dominguez, D., Batlle, E., . . . Baulida, J. (2002). Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. Journal of Biological Chemistry, 277(42), 39209-39216. doi:10.1074/jbc.M206400200
Iwai, N., Yasui, K., Tomie, A., Gen, Y., Terasaki, K., Kitaichi, T., . . . Itoh, Y. (2018). Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma. Int J Oncol, 53(1), 237-245. doi:10.3892/ijo.2018.4369
Jiao, D., Guo, F., & Fu, Q. (2019). MicroRNA-873 inhibits the progression of thyroid cancer by directly targeting ZEB1. Molecular Medicine Reports, 20(2), 1986-1993. doi:10.3892/mmr.2019.10381
Kinoshita, C., Aoyama, K., Matsumura, N., Kikuchi-Utsumi, K., Watabe, M., & Nakaki, T. (2014). Rhythmic oscillations of the microRNA miR-96-5p play a neuroprotective role by indirectly regulating glutathione levels. Nat Commun, 5, 3823. doi:10.1038/ncomms4823
Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J. H., & Semenza, G. L. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Research, 66(5), 2725-2731. doi:10.1158/0008-5472.Can-05-3719
Li, C., Du, X., Tai, S., Zhong, X., Wang, Z., Hu, Z., . . . Cui, Y. (2014). GPC1 regulated by miR-96-5p, rather than miR-182-5p, in inhibition of pancreatic carcinoma cell proliferation. Int J Mol Sci, 15(4), 6314-6327. doi:10.3390/ijms15046314
Liu, B., Zhang, J., & Yang, D. (2019). miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1. J Ovarian Res, 12(1), 57. doi:10.1186/s13048-019-0533-1
Lu, Y., Cao, D. L., Jiang, B. C., Yang, T., & Gao, Y. J. (2015). MicroRNA-146a-5p attenuates neuropathic pain via suppressing TRAF6 signaling in the spinal cord. Brain Behav Immun, 49, 119-129. doi:10.1016/j.bbi.2015.04.018
Luo, F., Wei, H. Y., Guo, H. Q., Li, Y., Feng, Y., Bian, Q., & Wang, Y. (2019). LncRNA MALAT1, an lncRNA acting via the miR-204/ZEB1 pathway, mediates the EMT induced by organic extract of PM2.5 in lung bronchial epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 317(1), L87-L98. doi:10.1152/ajplung.00073.2019
Ma, Z. H., Li, Y., Xu, J. C., Ren, Q. Z., Yao, J. H., & Tian, X. F. (2016). MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer. Iubmb Life, 68(5), 394-402. doi:10.1002/iub.1494
Mao, Z., Yao, M., Li, Y., Fu, Z., Li, S., Zhang, L., . . . Xia, Y. (2018). miR-96-5p and miR-101-3p as potential intervention targets to rescue TiO2 NP-induced autophagy and migration impairment of human trophoblastic cells. Biomater Sci, 6(12), 3273-3283. doi:10.1039/c8bm00856f
Ress, A. L., Stiegelbauer, V., Winter, E., Schwarzenbacher, D., Kiesslich, T., Lax, S., . . . Pichler, M. (2015). MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients. Mol Carcinog, 54(11), 1442-1450. doi:10.1002/mc.22218
Sakai, A., Saitow, F., Miyake, N., Miyake, K., Shimada, T., & Suzuki, H. (2013). miR-7a alleviates the maintenance of neuropathic pain through regulation of neuronal excitability. Brain, 136(Pt 9), 2738-2750. doi:10.1093/brain/awt191
Scholz, J., & Woolf, C. J. (2007). The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci, 10(11), 1361-1368. doi:10.1038/nn1992
Shao, S., Wang, C., Wang, S., Zhang, H., & Zhang, Y. (2019). LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis. Biomed Pharmacother, 117, 109082. doi:10.1016/j.biopha.2019.109082
Sun, S. N., Hang, T. Y., Zhang, B. Y., Zhu, L., Wu, Y., Lv, X. W., . . . Yao, H. H. (2019). miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway. American Journal of Translational Research, 11(9), 5338-5356.
van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014). Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain, 155(4), 654-662. doi:10.1016/j.pain.2013.11.013
Willemen, H. L., Huo, X. J., Mao-Ying, Q. L., Zijlstra, J., Heijnen, C. J., & Kavelaars, A. (2012). MicroRNA-124 as a novel treatment for persistent hyperalgesia. J Neuroinflammation, 9, 143. doi:10.1186/1742-2094-9-143
Woolf, C. J., & Mannion, R. J. (1999). Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet, 353(9168), 1959-1964. doi:10.1016/S0140-6736(99)01307-0
Wu, G. C., Zheng, H. T., Xu, J., Guo, Y. W., Zheng, G. B., Ma, C., . . . Wang, X. J. (2019). miR-429 suppresses cell growth and induces apoptosis of human thyroid cancer cell by targeting ZEB1. Artificial Cells Nanomedicine and Biotechnology, 47(1), 548-554. doi:10.1080/21691401.2018.1564320
Wu, P., Cao, Y., Zhao, R., & Wang, Y. (2019). miR-96-5p regulates wound healing by targeting BNIP3/FAK pathway. J Cell Biochem, 120(8), 12904-12911. doi:10.1002/jcb.28561
Xie, X., Ma, L., Xi, K., Zhang, W., & Fan, D. (2017). MicroRNA-183 Suppresses Neuropathic Pain and Expression of AMPA Receptors by Targeting mTOR/VEGF Signaling Pathway. Cell Physiol Biochem, 41(1), 181-192. doi:10.1159/000455987
Yang, D., Yang, Q., Wei, X., Liu, Y., Ma, D., Li, J., . . . Luo, Y. (2017). The role of miR-190a-5p contributes to diabetic neuropathic pain via targeting SLC17A6. J Pain Res, 10, 2395-2403. doi:10.2147/JPR.S133755
Yu, K., Li, N., Cheng, Q., Zheng, J., Zhu, M., Bao, S., . . . Shi, G. (2018). miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7. J Mol Med (Berl), 96(1), 65-74. doi:10.1007/s00109-017-1593-6